Health

Health economics outcomes research

We are passionate about helping clients robustly evaluate and communicate the value of their products.

From HTA-compliant cost-effectiveness and budget impact models to more holistic assessments of the wider value that therapies and other interventions can deliver to health systems and society, we apply scientific rigour to both traditional and innovative perspectives and methods.

How the life sciences sector can address the greatest health challenges and reduce inequalities

Health is one of our most untapped opportunities for prosperity and happiness, as both individuals and society. Yet these opportunities are not shared equally. The life sciences sector has a unique opportunity to actively reduce health inequalities, which we explore in our report.

Explore the report
ONS Health Index Explorer

See the health index in your area, how it has changed over time and compares to other local authorities.

Start here
Going swimmingly or treading water?

Read our on point paper which explores whether the elective recovery plan is bringing down NHS waiting lists.

Read the report
NHS waiting list tracker

Explore our interactive tracker to see how waiting lists for NHS services vary across England.

Start here

Combining deep knowledge with innovation

Our HEOR (health economics outcomes research) team navigates the complexities of generating robust evidence to meet the diverse requirements of payers, HTA (health technology assessments) agencies, healthcare providers, and local prescribers. Our team includes skilled health economists, evidence synthesis specialists, actuaries, and statisticians, who specialise in collating and synthesising clinical and economic evidence to clearly articulate the value a product offers for patients, healthcare systems, and broader society.

We combine our deep knowledge of HTA processes and requirements with an appetite for innovation. Our goal is to enhance the alignment between the valuation of medicines by HTA bodies and governments, and the broader value of health to patients, populations and economies.

Collaboration is at the heart of our approach

Working closely with our real-world evidence and market access colleagues, we ensure our guidance is holistic, integrating multiple perspectives for more effective and relevant outcomes. This synergy enhances our ability to deliver impactful solutions that resonate not only with our clients but also with their stakeholders.